Key Highlights
● TPG will take BILL private at $63.25 a share, about $6.0 billion.
● Intuit agreed to sell Mailchimp for about $3.68 billion.
● Palo Alto Networks announced a $4.5 billion all-stock deal for Applied Compute.
● Reported talks involving Sanofi, Insmed and NXP remain unconfirmed.
Even as stocks slid on Thursday, November 19, deal news kept coming: a $6 billion take-private of BILL, the $3.68 billion sale of Mailchimp, a $4.5 billion AI purchase Palo Alto (NASDAQ:PANW) Networks announced the evening before and a string of reported talks kept bankers and traders busy.
The signed deals
The biggest agreed transaction was for the payments and financial software company for small and midsize businesses. Private Equity firm TPG agreed to take BILL private for $63.25 a share in cash, valuing it at about $6.0 billion on a fully diluted basis. Corpay (NYSE:CPAY) will invest $1.1 billion for about a one-third stake and has an option to buy the rest in 2030.
Cybersecurity company Palo Alto Networks announced a $4.5 billion all-stock deal to acquire Applied Compute, a platform for post-training and running open-weight AI models. The deal was announced with record results after Wednesday's close, and Palo Alto was the S&P 500's best performer on Thursday.
Intuit (NASDAQ:INTU) agreed to sell its Mailchimp email Marketing Business to Bending Spoons for about $3.68 billion in enterprise value, a move that reshaped Intuit's Revenue guidance after the close.
Smaller deals rounded out the day. Private equity firm Wynnchurch completed its take-private of Luxfer, and Oliver Wyman agreed to acquire consultancy Synpulse. UGI (NYSE:UGI) unveiled plans to spin off its global LPG business.
The reported talks
Some of the day's most market-moving headlines were reports rather than announcements. A media report, citing people familiar with the matter, said Sanofi (NASDAQ:SNY) is studying a potential Acquisition of Insmed (NASDAQ:INSM) and working with advisers. No deal has been agreed, talks may not lead to one, and neither company commented. Insmed shares surged on the report.
Separately, a report said Takeover talks between Ambarella (NASDAQ:AMBA) and NXP Semiconductors (NASDAQ:NXPI) may be in their final stages. Neither company confirmed any talks, but Ambarella shares rose in early trading.
In Canada, the contest for TELUS (NYSE:TU) rolled on. Québecor's non-binding takeover proposal, made public on November 16, remains under review, and TELUS's board says it undervalues the company. A November 18 media report said BCE (NYSE:BCE) had held early talks with TELUS; that report was unconfirmed.
Restructuring and activism
Not every deal was a sale. Vivid Seats (NASDAQ:SEAT) signed an agreement with a group of its term lenders to swap about $273 million of secured Debt for new shares, a restructuring that would hand lenders most of the company's equity. The stock soared.
Activist investor Starboard Value, also BILL's largest shareholder, presented a plan to convert Riot Platforms (NASDAQ:RIOT) into a real estate Investment trust by early 2028.
Deals versus a falling market
The burst of activity contrasted sharply with the tape. The S&P 500 fell 147.80 points to 7,175.83, its sixth straight loss, and the Dow dropped 1,101.11 points to 49,097.06. Anthropic's (NASDAQ:ANT) $81.3 billion IPO, the largest on record, opened strongly but faded through the day. One newsletter editor said: "But don't mistake one blockbuster deal for an all-clear signal."
Busy deal flow during a sell-off is not unusual. Lower share prices can make targets cheaper, and buyers with long time horizons, such as private equity firms, may see value where public investors see risk.
What to watch
The BILL deal is expected to close in the first half of 2027, and Starboard and BILL CEO René Lacerte have agreed to vote in favor. Investors will watch for any confirmation, or denial, of the Sanofi-Insmed and NXP-Ambarella reports. In Canada, TELUS CEO Victor Dodig has invited Québecor CEO Pierre Karl Péladeau to meet on November 23. Rising interest rates, with a Fed hike widely expected on December 9, could also shape how much debt-financed deal-making continues.





_11_20_2026_12_38_15_908731.jpg)
Please wait processing your request...